CJC-1295 MOD GRF 1-29 / WITHOUT DAC - Research Grade Peptide

CJC-1295 MOD GRF 1-29 / WITHOUT DAC – Research Grade Peptide

For research purposes only. This product is supplied exclusively for scientific laboratory research and analytical purposes. It is not intended for human or animal use and must not be misused in any way that contravenes MHRA requirements or applicable laws.

• Research-grade synthetic 29-residue peptide with batch documentation available where supplied
• Modified GRF 1–29 structure without the C-terminal DAC modification
• Chromatographic purity of at least 99% where confirmed by the applicable batch Certificate of Analysis
• Supplied as lyophilised laboratory material in sealed flip-top headspace vials
• Batch identity, purity, peptide content and analytical specifications stated in the applicable Certificate of Analysis
• Handled and supplied exclusively as a research-use laboratory material

All of our research peptides and related laboratory materials are supplied strictly for scientific research and laboratory use only. Each vial contains lyophilised material prepared to support consistent laboratory handling and storage. The stated nominal amount refers to the declared CJC-1295 MOD GRF 1-29 / WITHOUT DAC peptide content of a single vial, subject to the applicable batch documentation. Where dissolution or reconstitution is required, the solvent, buffer, concentration, handling procedure and storage conditions stated in the applicable Certificate of Analysis, Safety Data Sheet or validated laboratory method should be followed. We do not provide advice or recommendations concerning dosage, administration or use in humans or animals.

Chemical Information:

• Product Name: CJC-1295 MOD GRF 1-29 / WITHOUT DAC
• Preferred Technical Description: Modified GRF (1–29)
• Alternative Names: Modified GRF 1–29; MOD GRF 1–29; CJC-1295 Without DAC; CJC-1295 No DAC; tetrasubstituted GRF 1–29
• Chemical Classification: Synthetic linear 29-residue peptide
• Sequence Length: 29 amino-acid residues
• Peptide Sequence: H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂
• One-Letter Sequence: Y-[D-Ala]-DAIFTQSYRKVLAQLSARKLLQDILSR-NH₂
• Sequence Modifications: D-alanine at position 2, glutamine at position 8, alanine at position 15 and leucine at position 27
• N-Terminal Structure: Free amino terminus
• C-Terminal Structure: C-terminal argininamide
• DAC Status: Without the additional C-terminal albumin-binding DAC modification
• Reported CAS Number: 863288-34-0
• PubChem Compound Identifier: CID 56841945
• Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
• Average Molecular Weight: Approximately 3367.95 g/mol
• Purity Specification: At least 99% chromatographic purity where confirmed by the applicable batch Certificate of Analysis and stated analytical method
• Physical Form: Lyophilised laboratory material, as stated in the applicable batch Certificate of Analysis
• Appearance: Refer to the applicable batch Certificate of Analysis
• Counter-Ion or Salt Form: Refer to the applicable Certificate of Analysis, as acetate, trifluoroacetate or another counter-ion may affect the recorded mass and net peptide content of the supplied material
• Product Distinction: This product does not contain the C-terminal modified lysine associated with the separate CJC-1295 product
• Identity Confirmation: Product identity should be confirmed using sequence records and mass-spectrometry data consistent with the specified 29-residue peptide
• Analytical Interpretation: Chromatographic purity, net peptide content, water content, residual solvent content and counter-ion content are separate analytical measurements and should be interpreted together

✓ Batch documentation – Certificate of Analysis documentation is provided where supplied for review.
✓ Certificate of Analysis – Accessible through the product QR code where provided for the applicable batch.
✓ Safety Data Sheet – Supplied to support appropriate laboratory handling, storage and regulatory compliance.
✓ Sequence documentation – Peptide sequence, residue substitutions and molecular identity should be confirmed using the applicable batch records.
✓ Mass-spectrometry documentation – Molecular identity should be supported by analytical mass data consistent with the specified peptide construct.
✓ Purity documentation – The reported chromatographic purity applies only to the analytical method and batch stated in the Certificate of Analysis.
✓ Peptide-content documentation – Net peptide content should be distinguished from chromatographic purity and interpreted alongside water and counter-ion results.
✓ Counter-ion documentation – Acetate, trifluoroacetate or another counter-ion should be identified and quantified where applicable.
✓ Supplier documentation – Reviewed where supporting synthesis, purification and analytical records are supplied.
✓ Fast, reliable and trackable delivery – Securely packaged and dispatched using insulated or temperature-controlled packaging where required by the applicable transport and storage specification.

For Research Use Only
This product is supplied strictly for scientific research, laboratory analysis and experimental work. It is not intended for human consumption, animal use, clinical use, diagnostic use or any form of therapeutic application.

CJC-1295 MOD GRF 1-29 / WITHOUT DAC Product Overview

Our CJC-1295 MOD GRF 1-29 / WITHOUT DAC research-grade synthetic peptide is supplied for controlled scientific laboratory investigation, analytical method development, peptide characterisation, high-performance liquid chromatography assessment and mass-spectrometry workflows. The material comprises a defined linear sequence of 29 amino-acid residues incorporating four specified sequence modifications and a C-terminal amide.

The material is handled with a focus on batch traceability, documented quality control and consistent laboratory presentation. Product identity, chromatographic purity, net peptide content, molecular form, amino-acid sequence, counter-ion content, water content, residual solvents, bacterial endotoxin results and other analytical specifications should be confirmed using the applicable batch Certificate of Analysis. Chromatographic purity should not automatically be interpreted as equivalent to the total net peptide content of the vial.

For the majority of routine analytical, investigative and general laboratory work, the Regular CJC-1295 MOD GRF 1-29 / WITHOUT DAC specification remains highly suitable. The premium black-and-gold ULTIMATE option provides an additional preparative high-performance liquid chromatography purification stage and a more stringent bacterial endotoxin and lipopolysaccharide testing specification for scientific projects requiring enhanced quality-control parameters.

View Certificate of Analysis

View Safety Data Sheet